Ma C P, Willy P J, Slaughter C A, DeMartino G N
Department of Physiology, University of Texas Southwestern Medical Center, Dallas 75235.
J Biol Chem. 1993 Oct 25;268(30):22514-9.
PA28, a protein activator of the 20 S proteasome, was previously identified in soluble extracts of bovine red blood cells (Ma, C.-P., Slaughter, C. A., and DeMartino, G. N. (1992) J. Biol. Chem. 267, 10515-10523). To determine whether this regulatory protein is as widely distributed as the proteasome, PA28 content and activity were examined in various eukaryotic tissues by immunoblot analysis and by functional assays of tissue extracts. PA28 protein was present in all sources examined. PA28 activity, however, was not detected in many of these sources, including those with the highest level of PA28 protein. To determine the biochemical basis of this result, PA28 was purified from extracts of rat liver, which had high levels of PA28 protein but no PA28 activity. The resulting purified PA28 had no detectable activity but had native and subunit molecular weights indistinguishable from the active PA28 of bovine red blood cells. Using the inactivation of purified PA28 as an assay, a protein that inactivated PA28 without altering its apparent molecular weight on SDS-polyacrylamide gel electrophoresis was identified, purified, and characterized from bovine liver. It had biochemical and catalytic characteristics similar to those of lysosomal carboxypeptidase B. When leupeptin, an inhibitor of lysosomal carboxypeptidase B, was included in the buffers used for the preparation of PA28, PA28 activity was detected in tissues which otherwise failed to demonstrate this activity. A similar result was obtained when extracts were prepared in a manner that minimized disruption of lysosomes. Other carboxypeptidases such as carboxypeptidase Y and pancreatic carboxypeptidase B also inactivated PA28 without altering its apparent molecular weight. Active PA28 binds to the proteasome to form a protease-activator complex that can be isolated after velocity sedimentation centrifugation through glycerol density gradients. Carboxypeptidase-inactivated PA28 failed to form such a complex, suggesting that the carboxyl terminus of PA28 is required for binding to the proteasome. These results indicate the importance of the carboxyl terminus of PA28 for proteasome activation.
PA28是20S蛋白酶体的一种蛋白质激活剂,先前在牛红细胞的可溶性提取物中被鉴定出来(马,C.-P.,斯劳特,C. A.,和德马蒂诺,G. N.(1992年)《生物化学杂志》267,10515 - 10523)。为了确定这种调节蛋白是否像蛋白酶体一样广泛分布,通过免疫印迹分析和组织提取物的功能测定,检测了各种真核组织中的PA28含量和活性。在所检测的所有来源中都存在PA28蛋白。然而,在许多这些来源中未检测到PA28活性,包括那些PA28蛋白水平最高的来源。为了确定这一结果的生化基础,从大鼠肝脏提取物中纯化了PA28,大鼠肝脏中PA28蛋白水平高但无PA28活性。所得纯化的PA28没有可检测到的活性,但其天然和亚基分子量与牛红细胞的活性PA28无法区分。以纯化的PA28失活作为检测方法,从牛肝脏中鉴定、纯化并表征了一种在SDS - 聚丙烯酰胺凝胶电泳上不改变其表观分子量就能使PA28失活的蛋白质。它具有与溶酶体羧肽酶B相似的生化和催化特性。当用于制备PA28的缓冲液中包含溶酶体羧肽酶B的抑制剂亮肽素时,在原本未能显示这种活性的组织中检测到了PA28活性。当以最小化溶酶体破坏的方式制备提取物时,也得到了类似的结果。其他羧肽酶,如羧肽酶Y和胰羧肽酶B,也能使PA28失活而不改变其表观分子量。活性PA28与蛋白酶体结合形成蛋白酶 - 激活剂复合物,该复合物可在通过甘油密度梯度的速度沉降离心后分离出来。羧肽酶失活的PA28无法形成这样的复合物,这表明PA28的羧基末端对于与蛋白酶体结合是必需的。这些结果表明PA28的羧基末端对于蛋白酶体激活的重要性。